ArticleBMC cancer2023

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements.

Byeong-Chan Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.